AGILIS BIOTHERAPEUTICS, INC.
Profile
Company Names
AGILIS BIOTHERAPEUTICS, INC.
AGILIS BIOTHERAPEUTICS, LLC
Addresses
245 FIRST STREET, SUITE 1800, CAMBRIDGE, MA 02142
5956 SHERRY LANE, SUITE 1810, DALLAS, TX 75225
Phone Numbers
(617)444-8706
(214)706-4340
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2013
State Incorporated:
DELAWARE
Total Amount Raised:
$20,668,727.00
Number of Funding Rounds:
2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2017-02-15
$12,668,727.00
$23,335,392.00
$10,666,665.00
Equity
1
2013-12-24
$8,000,000.00
INDEFINITE
INDEFINITE
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
G.
HOUSTON
HALL
EXECUTIVE OFFICER, DIRECTOR
IAN
RATCLIFFE
DIRECTOR
GLOBAL CELL SOLUTIONS INC
| STEMGENT INC
| STEMGENT, INC.
| ENZYMATICS INC
| FRESHAIR SENSOR LLC
| MITRA RXDX, INC.
| AGILIS BIOTHERAPEUTICS, INC.
| AVITIDE, INC.
| ACESSA HEALTH INC.
| SANDS CAPITAL PRIVATE GROWTH FUND III, L.P.
| NANOVIEW DIAGNOSTICS INC.
| SANDS CAPITAL VENTURES FUND-SLK, L.P.
| TECKRO, INC.
| SANDS CAPITAL PRIVATE GROWTH FUND III-DC, L.P.
| SCM-S72-1, LLC
| NANOVIEW BIOSCIENCES, INC.
| VITARA BIOMEDICAL, INC.
| SANDS CAPITAL GLOBAL VENTURE FUND III, L.P.
ALEXANDER
M.
SEAVER
EXECUTIVE OFFICER, DIRECTOR
ADRIAN
Z.
STECYK
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
